This page lists all known medications that could potentially lead to 'Plasmacytoma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

If you have multiple myeloma, cancerous plasma cells divide and grow inside your bone marrow. Plasma cells are white blood cells that make antibodies. Antibodies are part of your immune system. They ...

A 70-year-old white male, who had been diagnosed with IgA lambda multiple myeloma 4 months previously, was referred to the Mayo Clinic for further evaluation of anemia. The patient had required over ...

The incidence of multiple myeloma, solitary plasmacytoma, and extramedullary plasmacytoma has increased between 2003 and 2016. The rate of mortality for multiple myeloma decreased over that same ...

Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2017; 15: e538-e548. Pauleit D, Zimmermann A, ...

Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer We provide an overview on ...

Phase II study of PRO95780 plus rituximab in patients with relapsed follicular non-Hodgkin's lymphoma (NHL). Background: Solitary plasmacytoma is a rare plasma-cell neoplasm. We wanted to assess the ...

Extramedullary plasmacytomas are an unusual manifestation of multiple myeloma. Gastrointestinal plasmacytomas occur as discrete masses, usually involving either the stomach or colon, and can be ...

Extramedullary plasmacytoma and solitary plasmacytoma represent rare manifestations of plasma cell dyscrasias, where abnormal plasma cells accumulate as a single localised lesion. In the case of ...

Correct diagnosis of solitary plasmacytoma as the cause of gastrointestinal blood loss and anemia is important because localized plasmacytoma are radiosensitive. The treatment of choice for a ...

Background A 70-year-old white male diagnosed with IgA lambda multiple myeloma, who had been treated with two cycles of melphalan and prednisone, was evaluated for persistent anemia. He had required ...